SpiroS.G., DowdeswellI.R.G.Arterialized ear lobe samples for blood gas tensions.Br J Dis Chest1976; 70: 263–8.
3.
BureauM.A., LupienL., BéginR.Neural drive and ventilatory strategy of breathing in normal children and in patients with cystic fibrosis and asthma.Pediatrics1981; 2: 187–94.
4.
LandsL.C., HeigenhauserJ.F., JonesN.L.Analysis of factors limiting maximal exercise performance in cystic fibrosis.Clin Sci1992; 83: 391–7.
5.
SzeinbergA., EnglandS., MindorffC., FraserI.M., LevisonH.Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished, young adult male patients with cystic fibrosis.Am Rev Res Dis1985; 132: 766–9.
6.
MoorcroftA.J., DoddM.E., WebbA.K.Exercise limitations and training for patients with cystic fibrosis.J Disability Rehab (in press).
7.
MierA., RedingtonA., BrophyC., HodsonM., GreenM.Respiratory muscle function in cystic fibrosis.Thorax1990; 45: 750–2.
8.
O'NeillS., LeahyF., PasterkampH., TalA.The effects of chronic hyperinflation, nutritional status and posture on respiratory muscle strength in cystic fibrosis.Am Rev Res Dis1983; 128: 1051–4.
9.
SzeinbergA., EnglandS., MindorffC., FraserI.M., LevisonH.Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished, young adult male patients with cystic fibrosis.Am Rev Resp Dis1985; 132: 766–9.
10.
WebbA.K., DoddM.E., and MoorcroftJ.Exercise and cystic fibrosis.J R Soc Med1995; 88: 30–6.
11.
CerneyF., ArmitageL., HirschJ.A., BishopB.Respiratory and abdominal muscle responses to expiratory threshold loading in cystic fibrosis.J Appl Physiol1992; 72: 842–50.
12.
HowardP.Oxygen Therapy.Bristol: Wright,1987.
13.
SpierS., RivlinJ., HughesD., LevisonH.The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis.Am Rev Respir Dis1984; 129: 712–18.
14.
BazuayeE.A., StoneT.N., CorrisP.A., GibsonG.J.Variability of inspired oxygen concentration with nasal cannulas.Thorax1992; 47: 609–11.
15.
CostelloR.W., ListonR., McNicholasW.T.Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks,thorax1995; 50: 405–6.
16.
GouldG.A., ForsythI.S., FlenleyD.C.Comparison of two oxygen conserving nasal prong systems and the effects of nose and mouth breathing.Thorax1986; 41: 808–9.
CampbellE.J.M.How to use the venturi mask.Lancet1982; i: 1206.
19.
DavidsonJ A.H., HosieH.E.Limitations of pulse oximetry: respiratory insufficiency—a failure of detection.BMJ1993; 307: 372–3.
20.
HuttonP., Clutton-BrockT.The benefits and pitfalls of pulse oximetry.BMJ1993; 307: 457–8.
21.
ReisA.L., FarrowJ.T., ClausenJ.L.Accuracy of two ear oximeters at rest and during exercise in pulmonary patients.Am Rev Respir Dis1985; 132: 685–9.
22.
OrensteinD.M., CurtisS.E., NixonP.A., HartiganE.R.Accuracy of three pulse oximeters during exercise and hypoxaemia in patients with cystic fibrosis.Chest.
23.
StonehamM.D., SavilleG.M., WilsonI.H.Knowledge about pulse oximetry among medical and nursing staff.Lancet1994; 344: 1339–42.
24.
CaroneM., PatessioA., AppendiniL., PurroA., CzernickaE., ZanaboniS., DonnerC.F.Comparison of invasive and noninvasive saturation monitoring in prescribing oxygen during exercise in COPD patients.Eur Respir J1997; 10: 446–51.
25.
WebbA.K., EganJ.J., DoddM.E.The clinical management of cystic fibrosis patients awaiting and immediately following lung transplantation. In: DodgeJ.A., BrockD.J.H., WiddecombeJ.H., eds. Cystic Fibrosis Current Topics, Vol. 4. Chichester: Wiley, 1996.
26.
KuoC., LinS., WangJ.Aerosol, humidity and oxygen.Chest1991; 99: 1352–6.
27.
BardsleyP.A., HowardP.Cor pulmonale and home oxygen.Therapy Practitioner1986; 230: 565–71.
28.
DobsonM.B.Use of jet mixing devices with an oxygen concentrator.Thorax1992; 47: 1060–2.
29.
LockS.H., BlowerG., PrynneM., WedzichaJ.A.Comparison of liquid and gaseous oxygen for domiciliary use.Thorax1992; 47: 98–100.
30.
RobertsC.M., BellJ., WedzichaJ.A.Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking.Thorax1996; 51: 831–4.
31.
Code of Federal Regulations, Title 14 CFR, Part 25.841. Washington, DC: US Government Printing Office, 1986.
32.
CottrellJ.J.Altitude exposures during aircraft flight: flying higher.Chest1988; 92: 81–4.
33.
GongH.Air travel and oxygen therapy in cardiopulmonary patients.Chest1992; 101: 1104–13.
34.
OadesP.J., BuchdahlR.M., BushA.Prediction of hypoxaemia at high altitude in children with cystic fibrosis.BMJ1994; 308: 15–18.
35.
CramerD., WardS., GeddesD.Assessment of oxygen supplementation during air travel.Thorax1996; 51: 202–3.
36.
RoscoeA.H.The flightdeck environment and pilot health.Aviation Med1990; 111: 46–55.
37.
BergB.W., DillardT.A., RajagopolK.R., MehmW.J.Oxygen supplementation during air travel in patients with chronic obstructive lung disease.Chest1992; 101: 638–41.
38.
SmeetsF.Travel for technology-dependent patients with respiratory disease.Thorax1994; 49: 77–81.
39.
Cystic Fibrosis Trust.Holidays and Travel Abroad:Factsheet. Kent: CFT, 1997.